Recent Price Movement and Market Comparison
Marathon Nextgen’s shares have underperformed significantly against the broader market indices. Over the last week, the stock declined by 2.83%, compared to a modest 0.40% drop in the Sensex. The one-month performance shows a similar pattern, with the stock falling 4.03% while the Sensex dipped only 0.23%. Year-to-date, the stock has lost 8.83% of its value, in stark contrast to the Sensex’s gain of 8.12%. Over the past year, the stock’s decline of 12.96% is particularly notable given the Sensex’s 5.36% rise, highlighting Marathon Nextgen’s persistent underperformance.
On the day of 18-Dec, the stock touched an intraday low of ₹530, marking a 2.68% drop from previous levels. It has been trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a bearish trend. The stock has also recorded losses for four consecutive days, with a cumulative decline of 3.22% during this period. Despite this, investor participation has increased, as evidenced by a 24.21% rise in delivery volume on 17 Dec compared to the five-day average, suggesting that some investors are actively trading the stock amid the volatility.
This week's disclosed pick, a Large Cap from NBFC, comes with precise Target Price and analysis. Check if you're positioned right for this opportunity!
- - Precise target price set
- - Weekly selection live
- - Position check opportunity
Financial Health and Profitability Challenges
While Marathon Nextgen boasts some positive financial indicators, such as a very low debt-to-equity ratio of 0.03 times as of the half-year period ending September 2025 and a strong operating profit to interest coverage ratio of 20.30 times, these strengths are overshadowed by concerns over its ability to service debt. The company’s Debt to EBITDA ratio stands at a high 5.25 times, indicating a relatively weak capacity to manage its debt obligations efficiently.
The company’s return on capital employed (ROCE) averages 9.80%, which points to modest profitability relative to the total capital invested. This is further reflected in its return on equity (ROE) of 10.3%, which, while positive, is not sufficiently compelling given the stock’s valuation. Marathon Nextgen’s price-to-book value ratio of 1.6 suggests that the stock is trading at a premium compared to its peers’ historical averages, despite its recent underperformance.
Operating profit growth has been moderate, with an annualised increase of 18.57% over the last five years. Although profits have risen by 29.5% over the past year, this has not translated into positive stock returns, indicating a disconnect between earnings growth and market sentiment.
Market Sentiment and Institutional Influence
Institutional investors hold a significant 22.48% stake in Marathon Nextgen, which typically suggests confidence in the company’s fundamentals. However, the stock’s recent price decline and underperformance relative to the BSE500 index, which gained 2.20% over the last year, imply that broader market factors and valuation concerns are weighing on investor sentiment.
The stock’s liquidity remains adequate for trading, with a typical trade size of ₹0.03 crore based on 2% of the five-day average traded value. Despite this, the persistent downward pressure on the share price reflects cautious positioning by market participants, likely driven by the company’s high debt servicing risk and subdued profitability metrics.
Considering Marathon Nextgen? Wait! SwitchER has found potentially better options in Realty and beyond. Compare this Smallcap with top-rated alternatives now!
- - Better options discovered
- - Realty + beyond scope
- - Top-rated alternatives ready
Conclusion: Why Marathon Nextgen Is Falling
Marathon Nextgen Realty Ltd’s recent share price decline is primarily attributable to its underwhelming ability to service debt, as indicated by a high Debt to EBITDA ratio, and modest returns on capital employed. Despite some positive financial ratios and rising profits, the stock has failed to keep pace with market benchmarks, resulting in sustained underperformance over the past year and beyond.
The stock’s valuation remains relatively expensive compared to peers, which, combined with weak price momentum and trading below all major moving averages, has dampened investor enthusiasm. The increased trading volumes suggest active repositioning by investors, but the prevailing sentiment remains cautious given the company’s financial challenges and the broader market context.
Investors should weigh these factors carefully, considering both the company’s strengths and its limitations, before making investment decisions regarding Marathon Nextgen.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
